You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
現代製藥(600420.SH):證券簡稱擬變更為“國藥現代”
格隆匯 03-25 19:20

格隆匯 3 月 25日丨現代製藥(600420.SH)公佈,公司2021324日召開第七屆董事會第七次會議,以7同意,0反對,0棄權審議通過了《關於擬變更證券簡稱的議案》同意將公司證券簡稱由“現代製藥”變更為“國藥現代”公司證券代碼“600420”保持不變

公司隸屬於中國醫藥集團有限公司(“國藥集團”),20173完成重大資產重組後,定位為國藥集團旗下化學藥工業發展的統一平台截至2020年底,國藥集團及其下屬公司合計持有公司股權比例達到59.07%

為了深化公司戰略目標與定位促進中長期發展規劃的實施推進,加強品牌管理,統一和提升企業形象,同時增強證券簡稱辨識度,便於投資者理解,將證券簡稱由“現代製藥”變更為“國藥現代”為保證公司生產經營的延續穩定,公司全稱不作變更。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account